Fractalkine/CX3CL1: a potential new target for inflammatory diseases

Journal article

Open access

Brian A Jones, Maria Beamer and Salahuddin Ahmed

Molecular interventions, Vol.10(5), pp.263-270

10/2010

Handle:

https://hdl.handle.net/2376/112698

PMCID: PMC3002219

PMID: 21045240

Files and links (1)

url

https://doi.org/10.1124/mi.10.5.3View

Published (Version of record) Open

Inflammation - pathology

Animals

Anti-Inflammatory Agents - pharmacology

Inflammation - drug therapy

Models, Biological

Humans

Models, Molecular

Inflammation - immunology

Chemokine CX3CL1 - antagonists & inhibitors

Chemokine CX3CL1 - physiology

24 Record Views

Title: Fractalkine/CX3CL1: a potential new target for inflammatory diseases
Creators: Brian A Jones - Department of Pharmacology, College of Pharmacy, University of Toledo, OH, USA
Maria Beamer
Salahuddin Ahmed
Publication Details: Molecular interventions, Vol.10(5), pp.263-270
Academic Unit: Pharmaceutical Sciences, Department of
Publisher: United States
Grant note: R21 AT003633 / NCCIH NIH HHS R03 AR055741 / NIAMS NIH HHS AT-003633 / NCCIH NIH HHS AR-055741 / NIAMS NIH HHS
Identifiers: 99900547788101842
Language: English
Resource Type: Journal article